Skip to main content

Phreesia, Inc.

PHR
Exchange
NYSE
Industry
Services-Business Services, NEC
SEC CIK
0001412408

In the last 90 days, Phreesia, Inc. insiders filed 0 open-market purchases and 4 sales; 227 institutions reported holding it in 13F filings for Q2 2026, worth $598.3M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Phreesia, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
4 filings
3 insiders, $101.4K in total
Insiders trading
3
Net value
−$101.4K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Phreesia, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Phreesia, Inc.
NameTitleLast reported holdingLast filingFilings, past year
VanDuyn Amy BethSVP, Human Resources260,521Sep 22, 202610
Roberts EvanPresident, Provider Solutions1,038,138Sep 22, 202610
Linetsky DavidPresident, Network Solutions22,267IndirectSep 22, 202615
Hoffman Allison CGeneral Counsel & Secretary266,574Sep 22, 202613
Indig ChaimChief Executive Officer1,889,595Sep 3, 20267
Hui YvonnePrincipal Accounting Officer64,724Sep 3, 202614
Gandhi BalajiChief Financial Officer348,931Sep 3, 20268
Munson GillianDirector66,789Aug 3, 20265
Goldstein LainieDirector70,862Aug 3, 20265
Egbuonu-Davis LisaDirector37,780Jul 16, 20262
Kessler JonDirector43,884Jun 26, 20262
Smith Mark DouglasDirector56,643Jun 26, 20261
Sayar RaminDirector52,725Jun 26, 20261
Cahill Edward LDirector65,613May 4, 20263
Barta Jan10% Owner8,924,329IndirectApr 2, 20262
Pale Fire Capital SE10% Owner8,924,329IndirectApr 2, 20262
Senkypl Dusan10% Owner8,924,329IndirectApr 2, 20262
Pale Fire Capital SICAV a.s.10% Owner8,924,329IndirectApr 2, 20262
Pale Fire Capital investicni spolecnost a.s.10% Owner8,924,329IndirectApr 2, 20262
Weintraub MichaelDirector165,116Aug 27, 20250
Gunzburg JanetPrincipal Accounting Officer34,820Jun 24, 20240
Davidoff Michael J.SVP, Payer Business73,391Jan 18, 20240
Rasmussen RandyChief Financial Officer145,594Feb 6, 20230
Pegus CherylDirector15,825Feb 23, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 17, 2024 (view filing)Apr 152 daysHoffman Allison CGeneral Counsel & SecretarySSale−1.24K$22.86−$28.3K−0.9%135.6K after
Apr 17, 2024 (view filing)Apr 152 daysRoberts EvanChief Operating OfficerSSale−2.03K$22.86−$46.4K−0.3%754.9K after
Apr 17, 2024 (view filing)Apr 152 daysLinetsky DavidSVP, Life SciencesSSale−2.21K$22.86−$50.6K−1.1%204.0K after
Apr 17, 2024 (view filing)Apr 152 daysVanDuyn Amy BethSVP, Human ResourcesSSale−685$22.86−$15.7K−0.6%119.0K after
Apr 19, 2024 (view filing)Apr 181 dayLinetsky DavidSVP, Life SciencesSSale−269$22.85−$6.15K−3.7%7.09K after
Apr 19, 2024 (view filing)Apr 181 dayGunzburg JanetPrincipal Accounting OfficerSSale−912$22.85−$20.8K−2.5%35.2K after
May 2, 2024 (view filing)May 11 dayGunzburg JanetPrincipal Accounting OfficerSSale−286$21.00−$6.01K−0.8%34.9K after
Jun 21, 2024 (view filing)Jun 18-203 daysLinetsky DavidSVP, Life SciencesSSale−107$19.53−$2.09K−1.5%6.98K after2 lots
Jun 24, 2024 (view filing)Jun 213 daysLinetsky DavidSVP, Life SciencesSSale−27$20.24−$546.48−0.4%6.95K after
Jun 24, 2024 (view filing)Jun 213 daysGunzburg JanetPrincipal Accounting OfficerSSale−114$20.24−$2.31K−0.3%34.8K after
Jul 17, 2024 (view filing)Jul 161 dayRoberts EvanChief Operating OfficerSSale−1.67K$23.74−$39.6K−0.2%753.2K after
Jul 17, 2024 (view filing)Jul 161 dayVanDuyn Amy BethSVP, Human ResourcesSSale−374$23.74−$8.88K−0.3%118.6K after
Jul 17, 2024 (view filing)Jul 161 dayGandhi BalajiChief Financial OfficerSSale−783$23.74−$18.6K−0.8%96.4K after
Jul 17, 2024 (view filing)Jul 161 dayHoffman Allison CGeneral Counsel & SecretarySSale−800$23.74−$19.0K−0.6%135.1K after
Jul 17, 2024 (view filing)Jul 161 dayHui YvonnePrincipal Accounting OfficerSSale−283$23.74−$6.72K−1.0%28.7K after
Jul 17, 2024 (view filing)Jul 161 dayIndig ChaimChief Executive OfficerSSale−2.64K$23.74−$62.8K−0.2%1.22M after
Jul 17, 2024 (view filing)Jul 161 dayLinetsky DavidSVP, Life SciencesSSale−1.82K$23.74−$43.2K−0.9%202.2K after
Jul 22, 2024 (view filing)Jul 184 daysSmith Mark DouglasDirectorSSale−7.00K$25.00−$175.0K−18.6%30.7K after10b5-1
Jul 30, 2024 (view filing)Jul 291 dayIndig ChaimChief Executive OfficerSSale−7$24.75−$173.250.0%1.22M after10b5-1
Aug 28, 2024 (view filing)Aug 262 daysHoffman Allison CGeneral Counsel & SecretarySSale−14.1K$26.03−$367.3K−10.4%121.0K after
Sep 12, 2024 (view filing)Sep 10-112 daysHoffman Allison CGeneral Counsel & SecretarySSale−4.69K$23.30−$109.4K−3.7%121.0K after2 lots10b5-1
Sep 12, 2024 (view filing)Sep 102 daysVanDuyn Amy BethSVP, Human ResourcesSSale−737$23.25−$17.1K−0.6%119.5K after
Sep 12, 2024 (view filing)Sep 102 daysRoberts EvanChief Operating OfficerSSale−3.15K$23.25−$73.2K−0.4%755.7K after
Sep 12, 2024 (view filing)Sep 102 daysLinetsky DavidSVP, Life SciencesSSale−1.72K$23.25−$39.9K−0.8%203.3K after
Sep 12, 2024 (view filing)Sep 102 daysLinetsky DavidSVP, Life SciencesSSale−95$23.25−$2.21K−1.0%9.09K after
Sep 12, 2024 (view filing)Sep 102 daysIndig ChaimChief Executive OfficerSSale−5.29K$23.25−$123.1K−0.4%1.22M after
Sep 12, 2024 (view filing)Sep 102 daysHui YvonnePrincipal Accounting OfficerSSale−744$23.25−$17.3K−2.4%30.0K after
Sep 12, 2024 (view filing)Sep 102 daysGandhi BalajiChief Financial OfficerSSale−3.50K$23.25−$81.4K−3.4%98.6K after
Sep 13, 2024 (view filing)Sep 121 dayEgbuonu-Davis LisaDirectorSSale−1.40K$23.03−$32.2K−7.2%18.1K after
Sep 19, 2024 (view filing)Sep 17-182 daysLinetsky DavidSVP, Life SciencesSSale−97$24.34−$2.36K−1.1%8.99K after2 lots
Sep 20, 2024 (view filing)Sep 191 dayLinetsky DavidSVP, Life SciencesSSale−24$24.04−$576.96−0.3%8.97K after
Oct 17, 2024 (view filing)Oct 15-162 daysHui YvonnePrincipal Accounting OfficerSSale−3.21K$20.98−$67.4K−10.7%26.8K after3 lots10b5-1
Oct 17, 2024 (view filing)Oct 152 daysVanDuyn Amy BethSVP, Human ResourcesSSale−624$21.03−$13.1K−0.5%118.9K after
Oct 17, 2024 (view filing)Oct 152 daysRoberts EvanChief Operating OfficerSSale−1.84K$21.03−$38.8K−0.2%753.9K after
Oct 17, 2024 (view filing)Oct 152 daysLinetsky DavidSVP, Life SciencesSSale−2.01K$21.03−$42.3K−1.0%201.3K after
Oct 17, 2024 (view filing)Oct 152 daysIndig ChaimChief Executive OfficerSSale−3.09K$21.03−$65.0K−0.3%1.22M after
Oct 17, 2024 (view filing)Oct 152 daysHoffman Allison CGeneral Counsel & SecretarySSale−1.21K$21.03−$25.5K−1.0%119.8K after
Oct 17, 2024 (view filing)Oct 152 daysGandhi BalajiChief Financial OfficerSSale−864$21.03−$18.2K−0.9%97.7K after
Oct 22, 2024 (view filing)Oct 184 daysLinetsky DavidSVP, Life SciencesSSale−1.10K$20.49−$22.5K−0.5%200.2K after10b5-1
Dec 4, 2024 (view filing)Dec 22 daysWeintraub MichaelDirectorSSale−15.2K$21.01−$318.3K−5.9%242.8K after10b5-1
Dec 5, 2024 (view filing)Dec 32 daysVanDuyn Amy BethSVP, Human ResourcesSSale−25.4K$20.93−$532.6K−21.4%93.5K after10b5-1
Dec 12, 2024 (view filing)Dec 102 daysRoberts EvanChief Operating OfficerSSale−25.0K$24.09−$602.3K−3.3%728.9K after10b5-1
Dec 13, 2024 (view filing)Dec 112 daysLinetsky DavidSVP, Life SciencesSSale−11.9K$24.85−$294.5K−5.9%188.4K after10b5-1
Dec 13, 2024 (view filing)Dec 112 daysWeintraub MichaelDirectorSSale−18.6K$25.10−$466.2K−7.1%242.8K after10b5-1
Dec 17, 2024 (view filing)Dec 13-164 daysWeintraub MichaelDirectorSSale−21.4K$25.05−$536.7K−8.1%242.8K after2 lots10b5-1
Dec 18, 2024 (view filing)Dec 16-172 daysLinetsky DavidSVP, Life SciencesSSale−96$25.00−$2.40K−1.1%8.88K after3 lots
Dec 19, 2024 (view filing)Dec 181 dayLinetsky DavidSVP, Life SciencesSSale−24$25.38−$609.12−0.3%8.85K after
Dec 19, 2024 (view filing)Dec 181 dayHoffman Allison CGeneral Counsel & SecretarySSale−3.50K$24.88−$87.0K−2.9%116.3K after10b5-1
Jan 8, 2025 (view filing)Jan 62 daysLinetsky DavidSVP, Life SciencesSSale−3.13K$26.61−$83.4K−1.3%239.2K after
Jan 8, 2025 (view filing)Jan 62 daysHoffman Allison CGeneral Counsel & SecretarySSale−3.98K$26.61−$106.0K−2.4%159.1K after